Table 1 Biological agents, commercial stock solution concentrations, applied volumes, and final concentrations
From: Are biological agents toxic to human chondrocytes and osteocytes?
BA | Commercial stock solution concentration (mg/mL) | Applied volumes (μL/mL) | Final concentration (μL/mL) |
|---|---|---|---|
Rituximab (RIT) | 250 | 1 | 10 |
Adalimumab (ADA) | 500 | 0.2 | 10 |
Abatacept (ABA) | 40 | 1 | 10 |
Etanercept (ETA) | 50 | 0.4 | 10 |
Infliximab (INF) | 100 | 0.8 | 10 |